CyberdyneTSE:7779 78 EBITDA Margin % is 41.03% as of Mar. 2026, which is 1568% above its 10-year median of 2.46. GuruFocus rates TSE:7779 with a GF Score™ of 78/100 and a GF Value™ of 円195.48 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Cyberdyne ranks better than 95.47% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Cyberdyne's EBITDA for the
three
months ended in Mar. 2026 was 円391 Mil. Cyberdyne's Revenue for the
three
months ended in Mar. 2026 was 円953 Mil. Therefore, Cyberdyne's EBITDA margin for the quarter that ended in Mar. 2026 was 41.03%.
Cyberdyne (TSE:7779) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Cyberdyne EBITDA Margin % Related Terms
Cyberdyne EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Cyberdyne's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7779 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Cyberdyne's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cyberdyne EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cyberdyne's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Cyberdyne's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cyberdyne (TSE:7779) has a EBITDA Margin % of 41.03% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Cyberdyne and its competitors. This is 1568% above median its historical median of 2.46. According to the industry distribution chart, Cyberdyne ranks #37 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 4.5%.
Is Cyberdyne's EBITDA Margin % too high?
Cyberdyne's current EBITDA Margin % of 41.03% is 1568% above median its 10-year median of 2.46. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Cyberdyne's value of 41.03% is 448.9% above this industry median. Based on the distribution chart, Cyberdyne ranks #37 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Cyberdyne has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cyberdyne's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cyberdyne ranks #37 out of 816 companies for EBITDA Margin %. This places Cyberdyne in the top 5% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.48. Cyberdyne's value of 41.03% is 448.9% above this benchmark. While the company's 10-year median is 2.46 vs. the industry median of 7.48, Cyberdyne has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cyberdyne's current EBITDA Margin % of 41.03% is 448.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Cyberdyne and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cyberdyne's current EBITDA Margin % is 41.03%, which is 1568% above median its own 10-year median of 2.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cyberdyne stock overvalued right now?
Based on GuruFocus' analysis, Cyberdyne (TSE:7779) is currently considered Modestly Overvalued. The stock's GF Value™ is 円195.48, compared to a current price of 円250.00 — trading 27.9% above its estimated fair value. The current EBITDA Margin % is 41.03%, which is 1568% above median its 10-year median of 2.46 and 448.9% above the Medical Devices & Instruments industry median of 7.48. Cyberdyne's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Cyberdyne (TSE:7779), the current EBITDA Margin % is 41.03% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cyberdyne (TSE:7779) Overvalued in 2026?
Based on GuruFocus' analysis, Cyberdyne stock appears to be overvalued.
The current stock price of 円250.00 is trading 27.9% above its estimated GF Value™ of 円195.48.
GuruFocus considers Cyberdyne to be Modestly Overvalued.
Key valuation signals for TSE:7779:
EBITDA Margin %: 41.03% (1568% above median its 10-year median of 2.46)
GF Value™: 円195.48 vs. price of 円250.00 (27.9% above fair value)
Industry Position: 448.9% above the Medical Devices & Instruments median (#37 of 816)
No single metric tells the full story. See the TSE:7779 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cyberdyne Inc is a Japanese based company engaged in the research and development of medical welfare equipment and systems. It offers equipment and systems for rehabilitation support, body function support for elderly and disabled people, rescue support in disaster sites, entertainments, and heavy labor support in factories. Its products include Hybrid Assistive Limb (HAL) for the lower limb, single joint, lumbar, Table Interface and Cleaning Robots. In addition, it also offers services in respect to medical service and non-medical service which includes HAL therapy under medical service, and Hal fit and Robo care service under non-medical service.
78GF Score
Get the complete analysis for TSE:7779
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7779 has been successfully added to your 
